Latest "Achieve Work Life Balance Move Country" News Stories - Page: 3

16:52 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Achieve Work Life Balance Move Country" found in our extensive news archives from over 250 global news sources.

More Information about Achieve Work Life Balance Move Country on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Achieve Work Life Balance Move Country for you to read. Along with our medical data and news we also list Achieve Work Life Balance Move Country Clinical Trials, which are updated daily. BioPortfolio also has a large database of Achieve Work Life Balance Move Country Companies for you to search.

Showing "Achieve Work Life Balance Move Country" News Articles 51–75 of 19,000+

Monday 25th March 2019

Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX®) in Australia

Bone Biologics Corp. (OTCQB:BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, today has announced that it received Human Research Ethics Committee (HREC) approval on March 20, 2019, for the first center of a multicenter pilot clinical trial to evaluate NB1 (NELL-1/DBX®) in 30 patients in Australia. The ...

Flare Capital Partners Appoints Parth Desai as Senior Associate

Expands Investment Team to Reinvent the Business of Healthcare Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the addition of healthcare technology investor and experienced policy professional Parth Desai as a Senior Associate. “Parth has dedicated his

Arch Oncology Raises $50 Million Series B Financing

-- Financing to Advance Lead Anti-CD47 Antibody AO-176 in Ongoing Phase 1 Clinical Trial and Pipeline -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies, today announced a successful $50 million Series B financing. The Company plans to use the proceeds ...

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and conduct of clinical tria...

European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint

-- Company Intends to Submit European MAA in Mid-2019 -- -- Webcast and Conference Call Today at 8:30 a.m. EDT -- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its phase 3 European clinical trial of AR101 for the treatment of peanut allergy...

NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy

Completion of Phase 1 First-in-Human Trials of Cryopreserved, Off-The-Shelf haNK Cells Leads the Way to Pivotal Phase 2 Trials in Relapsed Merkel Cell Carcinoma Funding to Support INDs for First-in-Human Targeted Off-The-Shelf NK Cells (t-haNKs) with PD-L1 and CD-19 as Tumor Targets

New Cigna Research Reveals Many Americans Are More Stressed, Less Rested and Spending Less Time with Family and Friends

Cigna supports whole person health as key to addressing loneliness and improving overall well-being in America Global health service company Cigna released results of its annual global 360 well-being survey, Well and Beyond, which found that America is the ninth ranked country for health and well-being. Well and Beyond findings also reveal that ...

ZYUS To Acquire Clinical Software Platform from Ehave

Assets to further enhance ZYUS cannabinoid clinical trial program ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) has entered into a definitive asset purchase agreement (the “Agreement”) with Ehave, Inc. (OTCQB:EHVVF) (“Ehave”) for ZYUS to acquire a proprietary health informatics platform (the “Platform”). The total purchase price of CAD...

International SOS Foundation: 2019 Duty of Care Awards Announces Expert Judging Panel and Key Partnerships

The International SOS Foundation welcomes support of sector-leading expert judges* and key partners for 2019. The global Awards recognise organisations demonstrating their commitment to Duty of Care by protecting health and security of their global workforce. International SOS Foundation is proud to present Chubb, the world’s largest publicly tr...

IMV Inc. to Present at Two Upcoming Investor Conferences

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, today announced that IMV Chief Executive Officer Frederic Ors will present at the Spring Investor Summit and the HC Wainwright Global Life Sciences Conference during April 2019. Details on each conference and presentation are as follows: ...

Cresco Labs Receives Approval to Enter the Michigan Market

Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has completed the most comprehensive portion of Michigan’s application process, being pre-qualified for a cultivation and processing license by the Departm...

Castle Biosciences Announces Presentation of 5-Year Prospective, Multicenter Clinical Outcome Study Confirming Accuracy and Impact of Uveal Melanoma Test

Data presented at International Society of Ocular Oncology (ISOO) 2019 Conference Castle Biosciences, Inc., a cancer diagnostics company providing personalized genomic information to improve cancer management decisions, today announced that it will present five-year outcomes from a prospective, multicenter study showing that DecisionDx®-UM accu...

Martin Bauer Group Announces the Acquisition of BI Nutraceuticals

Combined product portfolio and manufacturing capabilities create unique botanical platform in North America The Martin Bauer Group is excited to announce the acquisition of BI Nutraceuticals, a leading full-service manufacturer and supplier of plant-based ingredients in the United States. The acquisition creates an extensive portfolio of botanical ingr...

Enterprise Therapeutics strengthens leadership team, appoints Amit D. Munshi as Non-Executive Chairman

Appointment brings significant commercial pharma experience as Enterprise Therapeutics’ two lead respiratory programmes are progressed towards the clinic Brighton, UK, 25 March 2019: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, tod...

IONTAS named Small Business of the Year at Cambridge News Business Excellence Awards 2019.

Cambridge, UK, 25 March 2019: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019. Marking their 26th year, the Awards highlight Cambridge’s best business talent, with winners selected by a panel of experts encompassing a broad rang...

Menu Innovation and Consumer Engagement Drive Impact for Aramark Healthy for Life 20 By 20

SOURCE: Aramark DESCRIPTION:Three years ago, Aramark teamed up with the American Heart Association as part of an innovative initiative called Healthy for Life® 20 By 20. The combined goal: To improve the health of Americans 20 percent by the end of 2020. Together, Aramark and the American Heart Association are achieving industry-leading menu impact across the millions of meals served in workplac...

InteRNA Appoints Andrea van Elsas, Ph.D. to Scientific Advisory Board

-- Co-inventor of original CTLA4-antibody and immuno-oncology innovator to expand the Company’s clinical development expertise -- InteRNA Technologies announced today the appointment of Andrea van Elsas, Ph.D., as a new member of the Company’s Scientific Advisory Board (SAB). Dr. van Elsas is an immuno-oncology expert with over 20 years of experien...

IONTAS named Small Business of the Year at Cambridge News Business Excellence Awards 2019

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019. Marking their 26th year, the Awards highlight Cambridge’s best business talent, with winners selected by a panel of experts encompassing a broad ra...

Thermo Fisher to buy Brammer Bio for $1.7B, expanding gene therapy offerings

The life sciences giant grows its ambitions in the pharma CDMO space with another acquisition, this time focused on viral vector production.

Shady Grove Fertility Adds Eighth Board Certified Reproductive Endocrinologist, Melanie Ochalski, M.D., to the Pennsylvania Medical Team

Dr. Melanie Ochalski is accepting new patient appointments in Shady Grove Fertility’s Lancaster, PA office, as SGF continues to expand services and provide more convenient access to highly specialized fertility care. LANCASTER, Pa. (PRWEB) March 25, 2019 Shady Grove Fertility (SGF), one of the nation’s premiere fertility centers, is proud to welcome Dr. Melanie Ochalski to the Pennsylvania me...

Activist investor escalates pressure on Allergan

Allergan's plan to "phase in" a split of CEO and chairman roles failed to win over Appaloosa, which called the move "a weak attempt to placate discontent."

Pipeline Watch: Phase III Readouts For Vibegron, Doria And Ameluz

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

She Was Dancing On The Roof And Talking Gibberish. A Special Kind Of ER Helped Her.

With mental health beds in short supply, emergency rooms increasingly have become the care of first and last resort for people in the grips of a psychiatric episode. Now, hospitals around the country are opening emergency units that calmly cater to patients with mental health needs.

See RTLS Leader and Innovator Sonitor® at AHCW19 - Booth DZ33

Sonitor, the global leader in ultrasound-based indoor positioning, showcases live and interactive demonstrations of its industry leading Sense™ and Forkbeard™ platforms for routine and advanced healthcare use cases in hospital and Aged Care settings Sonitor Technologies Inc., the first and only provider of ultrasound technology for Real-Time Locati...

Sackler Trust freezes new UK donations

Trust’s move comes as arts organisations face mounting pressure to stop accepting its gifts

Quick Search


News Quicklinks